Brian A. Potoski

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

Zubair Qureshi, David L. Paterson, Brian A. Potoski et al. · Antimicrobial Agents and Chemotherapy · 2012 · 563 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Ryan K. Shields, Brian A. Potoski, Ghady Haidar et al. · Clinical Infectious Diseases · 2016 · 428 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

Ghady Haidar, Nathan J Philips, Ryan K. Shields et al. · Clinical Infectious Diseases · 2017 · 276 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

Anton Y. Peleg, Brian A. Potoski, Rhonda S. Rea et al. · Journal of Antimicrobial Chemotherapy · 2006 · 250 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17